Megoxi 40 mg/ml oralna suspenzija
| Name | Megoxi 40 mg/ml oralna suspenzija |
|---|---|
| Marketing Authorisation Number | HR-H-105855471 |
| Active Substance | megestrolacetat |
| Composition | 1 ml oralne suspenzije sadrži 40 mg megestrolacetata |
| Pharmaceutical Form | oralna suspenzija |
| Manufacturer | Polfarmex S.A., Kutno, Poljska |
| Marketing Authorisation Holder | Bausch Health Ireland Limited, 3013 Lake Drive, Citywest Business Campus, Dublin 24, Irska |
| Marketing Authorisation Date | 29.11.2022 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/16-02/314 |
| Registration Number | 381-12-01/70-22-31 |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | L02AB01 |
| Medicinal product marketed in the Croatia | Trajni prekid opskrbe |
| SmPC | download |
| PL | download |
